Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Top Cited Papers
- 1 August 2012
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 22 (4) , 275-281
- https://doi.org/10.1016/j.semcancer.2012.01.011
Abstract
No abstract availableKeywords
Funding Information
- NIH (RO1CA115880, RO1CA84232)
This publication has 70 references indexed in Scilit:
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Ipilimumab success in melanoma provides boost for cancer immunotherapyNature Reviews Drug Discovery, 2010
- Myeloid-Derived Suppressor Cells: Linking Inflammation and CancerThe Journal of Immunology, 2009
- Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β1The Journal of Immunology, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cellsBlood, 2008
- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor CellsThe Journal of Immunology, 2008
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinThe Journal of Experimental Medicine, 2008
- Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1Journal of Biological Chemistry, 2008
- Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cellsBlood, 2008